Pemetrexed as Indispensable Drug for the Treatment of Non-Squamous Non-Small Cell Lung Cancer; The Role in Induction and Maintenance Therapy

Cancer Cell & Microenvironment
doi 10.14800/ccm.157
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Smart Science and Technology, LLC

Related search

Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy

Patient
Nursing
2018English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

Oncologist
Cancer ResearchMedicineOncology
2010English

Novel Drug-Resistance Mechanisms of Pemetrexed-Treated Non-Small Cell Lung Cancer

Oncotarget
Oncology
2018English

Shifting the Paradigm for Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Predictive Factors of Severe Toxicities of Pemetrexed-Containing Chemotherapy in Patients With Non-Squamous Non-Small Cell Lung Cancer

Journal of Cancer Therapy
2017English

Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

P3.01-05 Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy